PI
VNRX icon

PFG Investments’s VolitionRx Ltd VNRX Stock Holding History

PFG Investments’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,250
Closed -$5.05K – 1341
2026
Q1 		$5.05K Buy
+1,250
New +$5.97K ﹤0.01% 1188

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PFG Investments's VNRX Position: Q2 2026 in Review

PFG Investments sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 1,250 shares — an estimated $5.05K sold.

PFG Investments first reported a position in VNRX in Q1 2026 and held it in 1 quarter. The position peaked at $5.05K in Q1 2026. 24 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • PFG Investments reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
  • PFG Investments sold 1,250 VolitionRx Ltd shares in Q2 2026, an estimated $5.05K.
  • PFG Investments first reported a position in VolitionRx Ltd in Q1 2026 and held it in 1 quarter.
  • PFG Investments's VolitionRx Ltd position peaked at $5.05K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.